Clinical Trial Update: N-acetyl Cysteine and Patients with Non-alcoholic Fatty Liver Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update noting completion of a study evaluating N-acetylcysteine in patients with non-alcoholic fatty liver disease (simple steatosis).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Simple Steatosis Non Fatty Liver | Phase 3 | Status: COMPLETED